Immunicum reports positive phase I/II-data for the therapeutic cancer vaccine INTUVAX® in the treatment of kidney cancer

What we doOur approachPipelineTechnology
About usManagementBoardClinical Advisory BoardCareers
NewsroomPress ReleasesEventsPatient Stories
Investors

Back
Immunicum reports positive phase I/II-data for the therapeutic cancer vaccine INTUVAX® in the treatment of kidney cancer
 9:00:00 AM

Keep reading
Mendus AB: Mendus AB (publ) interim report April – June 2022Read